Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2011-5-25
pubmed:abstractText
Immunohistochemistry (IHC) and fluorescent in situ hybridisation (FISH) are currently the most commonly used methods to assess HER2 status. PCR-based assays allow quantitative determination of HER2 amplification (Q-PCR) or overexpression (Q-RT-PCR), but are not routinely used. We evaluated the relevance of Q-RT-PCR for HER2 status determination.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1532-1827
pubmed:author
pubmed:issnType
Electronic
pubmed:day
24
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1739-46
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.
pubmed:affiliation
AP-HP, Hosp Saint-Louis, Department of Biochemistry, Paris 75010, France. jacqueline.lehmann-che@sls.aphp.fr
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Evaluation Studies